The role of p53 in tumour suppression: Lessons from mouse models

Cellular and Molecular Life Sciences

Volumn 55, Issue 1, 1999, Pages 48-63

  Attardi, L D ^a   Jacks, T ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Apoptosis; Cancer; Cell cycle arrest; Mouse model; p53; Tumour suppressor gene

Indexed keywords

PROTEIN P53;

ALLELE; APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL DEATH; DNA DAMAGE; GENE DELETION; KNOCKOUT MOUSE; LYMPHOMA; MOUSE; NONHUMAN; ONCOGENE; REVIEW; SUPPRESSOR GENE; TRANSGENIC MOUSE;

ANIMALS; CELL CYCLE; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; DNA TUMOR VIRUSES; GENES, P53; GENES, TUMOR SUPPRESSOR; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; ONCOGENES;

EID: 0033028043     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050269     Document Type: Review

References (88)

1. 1 Lane D. P. and Benchimol S. (1990) p53: ocogene or antioncogene? Genes Dev. 4: 1-8
2. 2 Baker S. J., Markowitz S., Fearon E. R., Willson J. K. V. and Vogelstein B. (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915
3. 3 Greenblatt M. S., Hollstein M. and Harris C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855-4878
4. 4 Hollstein M., Sidransky D., Vogelstein B. and Harris C. C. (1991) p53 mutations in human cancers. Science 253: 49-53
5. 5 Prives C. (1994) How loops, β sheets, and α helices help us to understand p53. Cell 78: 543-546
6. 6 Mulligan L. M., Matlashewski G. J., Scrable H. J. and Cavenee W. K. (1990) Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA 87: 5863-5867
7. 7 Mulkin, D. (1993) p53 and the Li-Fraumeni syndrome. Cancer Genet. Cytogenet. 66: 83-92.
8. 8 Mowat M., Cheng A., Kimura N., Bernstein A. and Benchimol S. (1985) Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314: 633-636
9. 9 Ben-David Y. and Bernstein A. (1991) Friend virus-induced erythroleukaemia and the multistage nature of cancer. Cell 66: 831-834
10. 10 Lavigueur A., Maltby V., Mock D., Rossand J., Pawson T. and Bernstein A. (1989) High incidence of lung, bone and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol. 9: 3982-3991
11. 11 Lee J. M., Abrahamson J. L. A., Kandel R., Donehower L. A. and Bernstein A. (1994) Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53-deficient mice. Oncogene 9: 3731-3736
12. 12 Harvey M., Vogel H., Morris D., Bradley A., Bernstein A. and Donehower L. A. (1995) A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nature Genet. 9: 305-311
13. 13 Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Butel J. S. et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221
14. 14 Harvey M., McArthur M. J., Montgomery C. A., Butel J. S., Bradley A., Donehower L. A. et al. (1993) Spontaneous and carcinogen-induced tumors in p53-deficient mice. Nature Genet. 5: 225-229
15. 15 Donehower L. A., Harvey M., Vogel H., McArthur M. J., Montgomery J. C. A., Park S. H. et al. (1995) Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog. 14: 16-22
16. 16 Jacks T., Remington L., Williams B. O., Schmitt E. M., Halachmi S., Bronson R. T. et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7
17. 17 Purdie C. A., Harrison D. J., Peter A., Dobbie L., White S., Howie S. E. M. et al. (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9: 603-609
18. 18 Donehower L. A. (1996) The p53-deficient mouse: a model for basic and applied cancer studies. Sem. Cancer Biol. 7: 269-278
19. 19 Harvey M., McArthur M. J., Montgomery C. A. Jr., Bradley A. and Donehower L. A. (1993) Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7: 938-943
20. 20 Dittmer D., Pali S., Zambetti G., Chu S., Teresky A. K., Moore M. et al. (1993) Gain of function mutations in p53. Nature Genet. 4: 42-46
21. 21 Levine A. J. (1997) p53. the cellular gatekeeper for growth and division. Cell 88: 323-331
22. 22 Kemp C. J., Wheldon T. and Balmain A. (1994) p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet. 8: 66-69
23. 23 Ruggeri B., Camano J., Goodrow T., DiRado M., Bianchi A., Trono D. et al. (1991) Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res. 51: 6615-6621
24. 24 Ruggeri B., DiRado M., Zhang S. Y., Bauer B., Goodrow T. and Klein-Santo A. J. P. (1993) Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl. Acad. Sci. USA 90: 1013-1017
25. 25 Kemp C. J., Donehower L. A., Bradley A. and Balmain A. (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74: 813-822
26. 26 Kress S., Sutter C., Strickland P. T., Mukhtar H., Schweizer J. and Schwartz M. (1992) Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 52: 6400-6403
27. 27 Kanjilal S., Pierceall W. E., Cummings K. K., Kripke M. L. and Ananthaswamy H. N. (1993) High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res. 53: 2961-2964
28. 28 van Kranen H. J., de Gruijl F. R., de Vries A., Sontag Y., Wester P. W., Senden H. C. M. et al. (1995) Frequent p53 alterations but now incidence of ras mutations in UV-B-induced skin tumors of hairless mice. Carcinogenesis 16: 1141-1147
29. 29 Dumaz N., van Kranen H. J., de Vries A., Berg R. J. W., Wester P. W., van Kreijl C. F. et al. (1997) The role of UV-B light in skin carcinogenesis throught the analysis of p53 mutations in squamous cell carcinomas of hairless mice. Carcino-genesis 18: 897-904
30. 30 Li G., Ho V. C., Berean K. and Tron V. A. (1995) Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res. 55: 2070-2074
31. 31 Li G., Tron V. and Ho V. (1998) Induction of squamous cell carcinoma in p53-deficient mice after ultraviolet irradiation. J. Invest. Dermatol. 110: 72-75
32. 32 Ananthaswamy H. N., Louglin S. M., Cox P., Evans R. L., Ullrich S. E. and Kripke M. L. (1997) Sunlight and skin cancer: inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens. Nature Med. 5: 510-514
33. 33 Ziegler A., Jonason A. S., Leffell D. J., Simon J. A., Sharma H. W., Limmelman J. et al. (1994) Sunburn and p53 in the onset of skin cancer. Nature 372: 773-776
34. 34 Rumsby P. C., Davies M. J. and Evans J. G. (1994) Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Mol. Carcinog. 9: 71-75
35. 35 Matzinger S. A., Crist K. A., Stoner G. D., Anderson M. W., Pereira M. A., Steele V. E. et al. (1995) K-ras mutations in lung tumors from A/J and A/JXTSG-p53 F1 mice treated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothicoyanate. Carcinogenesis 16: 2487-2492
36. 36 Jerry D. J., Butel J. S., Donehower L. A., Paulson E. J., Cochran C., Wiseman R. W. et al. (1994) Infrequent p53 mutations in 7, 12-dimethylbenz(a)anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol. Carcinog. 9: 175-183
37. 37 Kemp C. J. (1995) Hepatocarcinogenesis in p53-deficient mice. Mol. Carcinog. 12: 132-136
38. 38 Tennant R. W., Spalding J. and French J. E. (1996) Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens. Mutat. Res. 365: 119-127
39. 39 Hursting S. D., Perkins S. N. and Phang J. M. (1994) Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl. Acad. Sci. USA 91: 7036-7040
40. 40 Hursting S. D., Perkins S. N., Brown C. C., Haines D. C. and Phang J. M. (1997) Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deficient and wild-type mice. Cancer Res. 57: 2843-2846
41. 41 Hursting S. D., Perkins S. N., Haines D. C., Ward J. M. and Phang J. M. (1995) Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res. 55: 3949-3953
42. 42 Lowe S. W., Schmitt E. S., Smith S. W., Osborne B. A. and Jacks T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
43. 43 Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L. et al. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852
44. 44 Rabbitts T. H. (1994) Chromosomal translocations in human cancer. Nature 372: 143-149
45. 45 Bosma M. and Carroll A. (1991) The scid mouse mutant: definition, characterization, and potential uses. Annu. Rev. Immunol. 9: 323-350
46. 46 Bogue M. A., Zhu C., Aguilar-Cordova F., Donehower L. A., Roth D. B. et al. (1996) p53 is required for both radiation-induced differentiation and rescue of V(D)J rearrangement in scid mouse thymocytes. Genes Dev. 10: 553-565
47. 47 Guidos C. J., Williams C. J., Grandal I., Knowles G., Huang M. T. F. and Danska J. S. (1996) V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10: 2038-2054
48. 48 Nacht M., Strasser A., Chan Y. R., Harris A. W., Schlissel M., Bronson R. T. et al. (1996) Mutations in the p53 and SCID genes cooperate in tumorigenesis. Genes Dev. 10: 2055-2066
49. 49 Liao M. J., Zhang X. X., Hill R., Gao J., Qumsiyeh M. B., Nichole W. et al. (1998) No requirement for V(D)J recombination in p53-deficient thymic lymphoma. Mol. Cell. Biol. 18: 3495-3501
50. 50 Nacht M. and Jacks T. (1998) V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Cell Growth Differ. 9: 131-138
51. 51 Horak E., Smith K., Bromley L., Le Jeune S., Greenall M., Lane D. et al. (1991) Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. Oncogene 6: 2277-2284
52. 52 Guy S. T., Webster M. A., Schaller M., Parsons T. J., Cardiff R. D. and Muller W. J. (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89: 10578-10582
53. 53 Li B., Rosen J. M., McMenamin-Blano J., Muller W. J. and Perkins A. S. (1997) neu/ERBB2 Cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol. Cell. Biol. 17: 3155-3163
54. 54 Tsukamoto A. S., Grosschedl R., Guman R. C., Parslow T. and Varmus H. E. (1988) Expression of the int-1 gene in transgenic mice is associated with mammary hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625
55. 55 Donehower L. A., Godley L. A., Aldaz C. M., Pyle R., Shi Y.-P., Pinkel D. et al. (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev. 9: 882-895
56. 56 Jones J., Attardi L., Godley L. A., Laucirica R., Medina D., Jacks T. et al. (1997) Absence of p53 in a mouse mammary tumour model promotes tumor cell proliferation with out affecting apoptosis. Cell Growth Differ. 8: 829-838
57. 57 Hundley J. F., Koester S. K., Troyer D. A., Hilsenbeck S. G., Subler M. A. and Windle J. J. (1997) Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol. Cell. Biol. 17: 723-731
58. 58 Blyth K., Terry A., O'Hara M., Baxter E. W., Campbell M., Stewart M. et al. (1995) Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10: 1717-1723
59. 59 Hsu B., Marin M. C., El-Nagger A. K., Stephens L. C., Brisbay S. and McDonnell T. J. (1995) Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11: 175-179
60. 60 Elson A., Deng C., Campos-Torres J., Donehower L. A. and Leder P. (1995) The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11: 181-190
61. 61 Condorelli G. L., Facchiano F., Valtieri M., Proietti F., Vitelli L., Lulli K. et al. (1996) T-Cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56: 5113-5119
62. 62 Curtis D. J., Robb L., Strasser A. and Begley C. G. (1997) The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice. Oncogene 15: 2975-2983
63. 63 Marin M. C., Hsu B., Meyn R. E., Donehower L. A., El-Naggar A. K. and McDonnell T. (1994) Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 9: 3107-3112
64. 64 Williams B. O., Remington L., Bronson R. T., Mukai S., Albert D. M., Dryja T. et al. (1994) Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature. Genet. 7: 480-484
65. 65 Van Dyke T. A. (1994) Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. Sem. Cancer. Biol. 5: 106.1-106.14
66. 66 Harvey M., Vogel H., Lee E. Y., Bradley A. and Donehower L. A. (1995) Mice deficient in both p53 and Rb develop tumours primarily of endocrine origin. Cancer Res. 55: 1146-1151
67. 67 Fearon E. R. and Vogelstein B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
68. 68 Clarke A. R., Cummings M. C. and Harrison D. J. (1995) Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Oncogene 11: 1913-1920
69. 69 McClatchey A. I., Saotome I., Mercer K., Crowley D., Gusella J. F., Bronson R. T. et al. (1998) Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes. Dev. 12: 1121-1133
70. 70 Westphal C. H., Rowan S., Schmaltz C., Elson A., Fisher D. E. and Leder P. (1997) atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nature Genet. 16: 397-401
71. 71 Cranston A., Bocker T., Retimair A., Palazzo J., Wilson T., Mak T. et al. (1997) Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nature Genet. 17: 114-118
72. 72 Cheo D. L., Meira L. B., Hammer R. E., Burns D. K., Doughty A. T. B. and Friedber E. C. (1996) Synergistic interactions between XPC and p53 mutations in double-mutant mice: neural tube abnormalities and accelerated UV radiation-induced skin cancer. Curr. Biol. 6: 1691-1694
73. 73 Symonds H., Krall L., Remington L., Saenz-Robles M., Lowe S., Jacks T. et al. (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711
74. 74 Bowman T., Symonds H., Gu L., Yin C., Oren M. and Van Dyke T. (1996) Tissue-specific inactivation of p53 tumor suppression in the mouse. Genes Dev. 10: 826-835
75. 75 Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Liebermann D. A. et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805
76. 76 Miyashita T. and Reed J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299
77. 77 Yin C., Knudson C. M., Korsmeyer S. J. and Van Dyke T. (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637-640
78. 78 Howes K. A., Ransom N., Papermaster D. S., Lasudry J. G. H., Albert D. M. and Windle J. J. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev. 8: 1300-1310
79. 79 Pan H. and Griep A. (1994) Altered cell-cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8: 1285-1299
80. 80 Pan H. and Griep A. E. (1995) Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes Dev. 9: 2157-2169
81. 81 Fukasawa K., Choi T., Kuriyama R., Rulong S. and Vande Woude G. F. (1996) Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747
82. 82 Harvey M., Sands A. T., Weiss R. S., Hegi M. E., Wiseman R. W., Pantazis P. et al. (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467
83. 83 Debbas M. and White E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7: 546-554
84. 84 Lowe S. W. and Ruley H. E. (1993) Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes Dev. 7: 535-545
85. 85 Hermeking H. and Eick D. (1994) Mediation of c-myc-induced apoptosis by p53. Science 265: 2091-2093
86. 86 Wagner A. J., Kokontis J. M. and Hay N. (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell-cycle arrest and the ability of p53 to induce p21 waf1/cip1. Genes Dev. 8: 2817-2830
87. 87 Macleod K., Hu Y. and Jacks T. (1996) Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15: 6178-6188
88. 88 Almog N. and Rotter V. (1997) Involvement of p53 in cell differentiation and development. Biochem. Biophys. Acta 1333: F1-F27